EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Sep. 10, 2009--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and
surface modification technologies to the healthcare industry, announced
today that Phil Ankeny, Senior Vice President and Chief Financial
Officer, will make a presentation to the investment community at the CL
King Best Ideas Conference on Thursday, September 17, 2009 at 8:00 a.m.
(ET) at the Omni Berkshire Place Hotel in New York City.
Interested parties may access a live webcast of the presentation by
logging on to the Investors section of the SurModics website at www.surmodics.com.
Investors are advised to visit the site at least 10 minutes before the
scheduled presentation to register, download and install any necessary
multimedia streaming software. The software plug-ins required for the
live event can be either RealPlayer or Windows Media Player. The audio
file of this webcast will be archived and available on the Company's
site for 30 days.
About SurModics, Inc.
SurModics’ vision is to extend and improve the lives of patients through
technology innovation. The Company partners with the world’s foremost
medical device, pharmaceutical and life science companies to develop and
commercialize innovative products that result in improved diagnosis and
treatment for patients. Core offerings include: drug delivery
technologies (coatings, microparticles, nanoparticles, and implants);
surface modification coating technologies that impart lubricity,
prohealing, and biocompatibility capabilities; and components for in
vitro diagnostic test kits and specialized surfaces for cell culture and
microarrays. SurModics is headquartered in Eden Prairie, Minnesota and
its SurModics Pharmaceuticals subsidiary is located in Birmingham,
Alabama. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this release or part of
any filings the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Phil Ankeny, Senior Vice President and Chief
Financial Officer
(952) 829-2700
